GiHF Medcast
GiHF Medcast
Podcast Description
The official podcast channel for the GI Health Foundation. GiHF Medcast delivers expert-led conversations, clinical insights, and the latest in gastroenterology. Designed for healthcare professionals, each episode explores evidence-based strategies and emerging research to elevate patient care.
The Gi Health Foundation is a nonprofit 501(c)(3) educational organization dedicated to increasing awareness of the effect of gastrointestinal disorders in the United States. The foundation's goal is to provide health professionals with the most current education and information on gastrointestinal health.
Podcast Insights
Content Themes
The podcast explores critical themes in gastroenterology, including pediatric nutrition, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastrointestinal infections. Episodes highlight topics such as evidence-based approaches to managing conditions like EoE, CSID, and gastroparesis, with practical insights and emerging research critical to patient care.

The official podcast channel for the GI Health Foundation. GiHF Medcast delivers expert-led conversations, clinical insights, and the latest in gastroenterology. Designed for healthcare professionals, each episode explores evidence-based strategies and emerging research to elevate patient care.
The Gi Health Foundation is a nonprofit 501(c)(3) educational organization dedicated to increasing awareness of the effect of gastrointestinal disorders in the United States. The foundation’s goal is to provide health professionals with the most current education and information on gastrointestinal health.
What’s new in irritable bowel syndrome (IBS) management, and how are emerging therapies, digital health innovations, and personalized medicine shaping the future of GI care? In this episode of the Gut Feelings Podcast, gastroenterology experts Dr. Brennan Spiegel of Cedars-Sinai and Dr. Leila Neshatian of Stanford University discuss the latest advancements in IBS diagnosis, treatment, and patient-centered care. From emerging pharmacological therapies and gut-directed cognitive behavioral therapy (CBT) to virtual reality-based digital therapeutics, they explore evolving approaches to managing IBS symptoms and improving patient outcomes. The conversation also highlights the growing importance of biomarkers and personalized treatment strategies for IBS subtypes, including IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), and mixed IBS (IBS-M). Additionally, the experts examine the potential role of GLP-1 receptor agonists in gastrointestinal motility, their impact on symptoms such as constipation, diarrhea, and nausea, and emerging research into their potential applications in IBS-related abdominal pain. They also discuss the importance of assessing quality of life as a measure of treatment success, addressing challenging symptoms such as bloating, and incorporating a holistic, biopsychosocial approach to disorders of gut-brain interaction (DGBIs). Finally, discover how artificial intelligence (AI), digital health technologies, and advances in biomarker identification may help transform IBS diagnosis, patient phenotyping, and individualized treatment decisions. Tune in for expert perspectives on the evolving landscape of IBS management and the future of personalized gastroenterology care.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.